US2012136141A1PendingUtilityA1
Integrin Heterodimer And A Subunit Thereof
Est. expiryApr 2, 2018(expired)· nominal 20-yr term from priority
Inventors:Evy Lundgren-Akerlund
A61P 9/10A61P 41/00A61P 9/00A61P 35/00A61P 29/00A61P 19/00A61P 21/00G01N 33/68A61P 19/02C07K 14/70546A61K 38/00C07K 16/2839
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A recombinant or isolated integrin heterodimer comprising a novel subunit α10 in association with a subunit β is described. The integrin or the subunit α10 can be used as a marker or target of various types of cells, e.g. of chondrocytes, osteoblasts, and fibroblasts. The integrin or the subunit α10 can be used as a marker or target in different physiological or therapeutic methods. They can also be used as active ingredients in pharmaceutical compositions and vaccines.
Claims
exact text as granted — not AI-modified1 . A recombinant or isolated collagen binding integrin subunit α10 comprising essentially the amino acid sequence shown in SEQ ID No. 1 or SEQ ID No. 2, or homologues or fragments thereof having essentially the same biological activity.
2 .- 134 . (canceled)Join the waitlist — get patent alerts
Track US2012136141A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.